MATERIAL FOR BONE IMPLANTS AND METHOD OF PRODUCING SAME
20210353827 · 2021-11-18
Inventors
Cpc classification
A61L2300/112
HUMAN NECESSITIES
C08L89/04
CHEMISTRY; METALLURGY
C08L89/04
CHEMISTRY; METALLURGY
A61L27/18
HUMAN NECESSITIES
A61L2420/06
HUMAN NECESSITIES
C08L89/06
CHEMISTRY; METALLURGY
A61L2430/02
HUMAN NECESSITIES
C08L89/06
CHEMISTRY; METALLURGY
A61L2420/04
HUMAN NECESSITIES
International classification
A61L27/18
HUMAN NECESSITIES
A61L27/22
HUMAN NECESSITIES
Abstract
The present invention relates to a material for bone implants, comprising: a surface of oxidic ceramic materials, titanium or polyether ether ketone (PEEK) or other polymer or composite materials, a matrix of collagen or gelatin, which is covalently bound to said surface, and calcium phosphate embedded into said matrix. The present invention further relates to a method for producing the material according to the invention, to bone implants comprising the material according to the invention, and to its use as a bone implant material.
Claims
1. A method for producing a material for bone implants, comprising the steps of: (a) providing a surface comprising a material selected from the group consisting of oxidic ceramic materials and polyether ether ketone (PEEK), (b) covalently coupling a matrix, comprising collagen, gelatin, or combinations thereof, to the surface, and (c) mineralizing the matrix with calcium phosphate, wherein the surface comprises polyether ether ketone (PEEK) and the collagen, gelatin, or combinations thereof is bound to the PEEK by a linker selected from the group consisting of a dicarboxylic acid linker, a maleimide linker, and a hexamethylene diisocyanate linker.
2. The method according to claim 1, wherein the surface comprises polyether ether ketone (PEEK).
3. The method according to claim 1, wherein the material for bone implants comprises: (a) a surface comprising a material selected from the group consisting of oxidic ceramic materials and polyether ether ketone (PEEK), (b) a matrix covalently bound to the surface, the matrix comprising collagen gelatin, or combinations thereof, and (c) a calcium phosphate embedded into the matrix.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The construction and method of operation of the invention, however, together with additional objects and advantages thereof will be best understood from the following description of specific embodiments when read in connection with the accompanying drawings.
[0026] The figures show:
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
DETAILED DESCRIPTION OF THE INVENTION
[0061] In particular, a subject matter of the present invention relates to a material for bone implants, comprising: [0062] (a) a surface comprising a material selected from the group consisting of oxidic ceramic materials, titanium, polymer materials, and composite materials, [0063] (b) a matrix covalently bound to this surface, comprising collagen and/or gelatin, and [0064] (c) calcium phosphate embedded into this matrix.
[0065] The terms “material for bone implants” and “bone implant material” are used synonymously herein. The inventive material for bone implants has bioactive properties. As used herein, the term “bioactive” refers to the property of the inventive material for bone implants of permitting rapid growth into the surrounding tissue and ensuring a rapid and long-lasting fixation of the implant in the body. This property results solely from the technical features defined in the above subitems (a) to (c).
[0066] The inventive material for bone implants is applied to solid materials or bodies, which are used as a bone implant. These bodies may have any desired or required three-dimensional shape. Preferably, the entire surface of the inventive material for bone implants comprises the material defined in the above subitem (a) or is composed thereof. Suitable materials to which the inventive material can be applied may be selected from ceramic materials, metals, polymers, composite materials or combinations thereof well-known in the prior art.
[0067] The surface of the inventive material for bone implants comprises a material selected from the group consisting of oxidic ceramic materials, titanium, polymer materials, in particular polyether ether ketone (PEEK), and composite materials, or is composed thereof. Suitable oxidic ceramic materials, polymer materials, and composite materials are known in the prior art. In a preferred embodiment, the material is PEEK. This material is mechanically very similar to native bone material and well thus suitable as a bone implant material.
[0068] Specifically, the inventive material for bone implants comprises a matrix covalently bound to the surface, said matrix comprising collagen, preferably type I collagen and/or gelatin. In certain embodiments, this matrix consists of collagen, preferably type I collagen and/or gelatin. Gelatin is a denatured form of collagen and is more cost-effective and easier to handle compared thereto. Therefore, the use of gelatin as the matrix material is preferred. Methods for covalently bonding a matrix of collagen and/or gelatin to a surface will be described hereinafter. The covalently bound matrix typically has a layer thickness of 100 to 150 nm, but may also be thicker or thinner. In particular, the covalently bound matrix may have a layer thickness of 1 nm to 10 nm, preferably from 10 nm to 1 nm, more preferably from 20 nm to 500 nm, more preferably from 30 nm to 300 nm, more preferably from 50 nm to 200 nm, and most preferably from 100 to 150 nm. Further, the covalently bound matrix preferably covers the entire surface of the inventive material for bone implants.
[0069] Finally, the inventive material for bone implants comprises calcium phosphate embedded into said matrix, preferably calcium orthophosphate in all mineral forms, particularly preferably selected from the group consisting of amorphous calcium orthophosphate (ACP), dicalcium phosphate dihydrate (DCPD; brushite), octacalcium phosphate, and hydroxyapatite, also with partial fluoride, chloride or carbonate substitution, wherein ACP, hydroxyapatite, and octacalcium phosphate are particularly preferred. Methods for embedding said calcium phosphates into a corresponding matrix will be described hereinafter.
[0070] In a preferred embodiment, the inventive material for bone implants comprises PEEK or is composed thereof, wherein the collagen and/or gelatin of the covalently bound matrix are bound to the PEEK via a linker selected from the group consisting of a dicarboxylic acid linker, a maleimide linker, and a hexamethylene diisocyanate linker. Corresponding linkers are known in the prior art. Methods for covalently bonding collagen and/or gelatin to PEEK will be described hereinafter.
[0071] In other embodiments, the inventive material for bone implants comprises oxidic ceramic materials, titanium, polymer materials, or composite material, or is composed thereof, wherein the collagen and/or gelatin of the covalently bound matrix are bound via a silane linker. Suitable silane linker and corresponding methods for bonding collagen and/or gelatin are known in the prior art.
[0072] In a particularly preferred embodiment, the present invention relates to a material for bone implants, comprising: [0073] (a) a surface consisting of PEEK, [0074] (b) a matrix covalently bound to this surface, consisting of gelatin, and [0075] (c) hydroxyapatite embedded into this matrix.
[0076] Another subject matter of the present invention relates to a method for producing an inventive material for bone implants, comprising the steps of: [0077] (a) providing a surface comprising a material selected from the group consisting of oxidic ceramic materials, titanium, polymer materials, and composite materials, [0078] (b) covalently coupling a matrix, comprising collagen and/or gelatin, to this surface and [0079] (c) mineralizing the matrix with calcium phosphate.
[0080] To this subject matter of the present invention, all relevant definitions and preferred embodiments described above for the inventive material for bone implants apply analogously.
[0081] Methods for covalently coupling a matrix comprising collagen and/or gelatin to a surface according to step (b) of the inventive method are not particularly limited and are known in the part art.
[0082] In a preferred embodiment, the surface comprises PEEK or consists thereof, and step (b) of the inventive method comprises the steps of: [0083] (b1) activating the surface by reducing the keto group of the PEEK to form a hydroxyl group, [0084] (b2) covalently coupling a linker molecule selected from the group consisting of a dicarboxylic acid linker, a maleimide linker, and a hexamethylene diisocyanate linker to this activated surface, and (b3) covalently coupling the collagen and/or gelatin to the linker molecule.
[0085] Methods for reducing the keto group of PEEK to form a hydroxyl group are not particularly limited and, for example, comprise incubating the surface with a solution of sodium borohydride and dimethyl sulfoxide or a solution of lithium aluminum hydride in organic solvents.
[0086] Methods for coupling linker molecules to a correspondingly activated PEEK surface also are not particularly limited. In cases where the linker molecule is a dicarboxylic acid linker, the methods comprise e.g. incubating the surface with a solution containing the corresponding dicarboxylic acid, N,N′-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in tetrahydrofuran (THF). In cases where the linker molecule is a maleimide linker, the methods e.g. comprise incubating the surface with a solution containing triphenylphosphine, diethyl azodicarboxylate, and maleimide in THF. In cases where the linker molecule is a hexamethylene diisocyanate linker, the methods e.g. comprise incubating the surface in an inert gas atmosphere and dry reaction conditions with a solution containing hexamethylene diisocyanate and catalytic amounts of 1,4-diazabicyclo[2.2.2]octane (DABCO) in toluene.
[0087] Methods for coupling collagen and/or gelatin to corresponding linker molecules are not particularly limited and are known in the prior art. If the linker molecule is a dicarboxylic acid for example, step (b3) of the method according to the invention comprises incubating the surface with a 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)/N-hydroxysuccinimide (NHS) solution (EDC/NHS solution), and subsequently incubating the surface with a solution containing collagen and/or gelatin. If the linker molecule is a maleimide linker or a hexamethylene diisocyanate linker, step (b3) of the method according to the invention comprises incubating the surface with a solution containing collagen and/or gelatin.
[0088] Methods for mineralizing a matrix containing collagen and/or gelatin with calcium phosphates according to step (c) of the method according to the invention are not particularly limited. In the case that ACP is used, they comprise e.g. incubating the surface with a solution comprising calcium chloride, dipotassium phosphate, and a nucleation inhibitor. This nucleation inhibitor is preferably a non-collagenous protein or protein analogue, more preferably poly-aspartic acid and/or fetuin. In the event that hydroxyapatite is used, they comprise e.g. incubating the surface with a solution comprising calcium chloride and dipotassium phosphate.
[0089] Another subject matter of the present invention relates to a bone implant comprising a solid material and/or a solid body to which the inventive bone implant material is applied.
[0090] To this subject matter of the present invention, all relevant definitions and preferred embodiments described above for the inventive material for bone implants apply analogously.
[0091] Another subject matter of the present invention relates to the use of the inventive material for bone implants as a bone implant material.
[0092] To this subject matter of the present invention, all relevant definitions and preferred embodiments described above for the inventive material for bone implants apply analogously.
[0093] Another subject matter of the present invention relates to the use of the inventive material for bone implants for treating bone damage, for example.
[0094] To this subject matter of the present invention as well, all relevant definitions and preferred embodiments described above for the inventive material for bone implants apply analogously.
[0095] Another subject matter of the present invention relates to the use of the inventive bone implant for treating bone damage, for example.
[0096] To this subject matter of the present invention as well, all relevant definitions and preferred embodiments described above for the inventive material for bone implants apply analogously.
[0097] The better the implant surface corresponds to the natural bone, the better implants grow into the human body and are more stably connected to the body (among others, by increased accumulation of body cells). This is the object of the present invention. The chemical composition and especially the surface structure of the coating down to the micro- and even nanometer range is to come as close to the natural bone structure as possible according to the invention. Further, the coating is to be bound covalently to the surface of the implants. The bone implant materials of the invention have a higher biocompatibility, better healing into the natural bone, and an increased mechanical load-bearing capacity.
[0098] The surface modification according to the present invention aims at applying bone-like structures to the surface of the bone implant materials in a covalently bound manner, which include both the protein and the mineral phases of natural bone. This is to support healing of the implant into the bone. These structures include a matrix of denatured collagen, gelatin, which is finally mineralized with calcium phosphate. Here, mineralization takes place with the aid of non-collagenous proteins and their analogues, which act as nucleation inhibitors, so that the mineralization occurs in a controlled way and ectopic mineralization is avoided. Such nucleation inhibitors are, for example, poly-aspartic acid or fetuin. Mineralization with octacalcium phosphate or hydroxyapatite takes place by incubating the gelatin matrix in a solution containing calcium ions or phosphate ions. By a slow and controlled addition of a solution of the respectively complementary phosphate ions or calcium ions, octacalcium phosphate and/or hydroxyapatite can be precipitated within the gelatin matrix. Due to the relatively disordered structure of the gelatin, the resulting surface modification has a woven bone-like or callus-like structure. Thus, during healing of the material, the bone cells could build more disordered collagen structures around the material or link the material directly further to the bone. These disordered structures can finally be rebuild into ordered bone structures in the natural remodeling phase of bone healing. Here, however, the cells cannot penetrate up to the direct surface of the implant material due to the covalent bonding of the proteins in the remodeling phase, and thus always remain in a desired matrix of extracellular proteins. The implant material is thus masked for the cells to avoid adverse reactions in the healing of implants. Since the modification only relates to the surface of the implant materials, material properties are not changed.
[0099] The basic chemical reactions can be easily adapted for the modification of various materials. For example, metal oxide surfaces can be covalently bound via established silane chemistry. This makes the surface coating of the invention attractive also with respect to oxide ceramics. Furthermore, as metals can be oxidized easily on the surface by plasma treatment, also the common implant materials made of titanium become accessible to the inventive surface modification by silanes via silane chemistry.
[0100] The present invention will be explained on the basis of the following non-limiting examples.
Example 1
Analysis of Unmodified PEEK Material
[0101] The purchased material was PEEK optima by Invibio, Hofheim. These sheets had an amorphous structure and therefore appeared transparent with a white-beige color. An ATR-IR spectrum of the unmodified material can be seen in
[0102] Furthermore, the surface was examined with X-ray photoelectron spectroscopy (XPS). An overview spectrum is shown in
TABLE-US-00001 TABLE 1 Summary of the results of XPS analysis of unmodified PEEK. Component Element Element/ BE Composition Concentration Assignment Transition [eV] [at. %] [at. %] Carbon C 1s 284.7 75.6 74.52 C 1s 286.3 17.7 C 1s 287.1 3.6 C 1s 291.4 3.1 Oxygen O 1s 531.1 26.4 24.28 O 1s 533.3 73.6 Nitrogen N 1s 100 1.2
[0103] Furthermore, NMR spectroscopic studies with CF.sub.3SO.sub.3D as a solvent were carried out. The .sup.1H-NMR spectrum is shown in
[0104] The surface of the material was further characterized using atomic force microscopy (AFM). The results are shown in
[0105] An important factor for increasing the biocompatibility is to increase the hydrophilic nature of the surface of the material, as this results in excellent wetting by the blood and body fluid present in the surgical wound of the bone and the related adhesion of osteogenesis-stimulating factors. Thus, a complementary surface characterization was carried out by water contact angle measurements. The contact angle was 89°±1°. This corresponds to low hydrophily or low wettability of the material.
Example 2
Wet-Chemical Modifications of PEEK—Reduction to PEEK-OH
[0106] In order to increase the biocompatibility of the material, the surface needs to be activated at first in order to chemically bond biopolymers, such as gelatin, afterward.
[0107] In the case of the PEEK material, the keto group was at first reduced to a hydroxyl group to serve as an anchor point between the gelatin layer and the material for the subsequent coupling reactions. This was done according to a modification known in the prior art. To this end, a PEEK sheet was immersed in a solution of sodium borohydride in dimethylsulphoxide. The resulting product PEEK-OH will be mentioned hereinafter.
[0108] To verify the success of the reaction, NMR spectroscopy has been used (
[0109] Also, the aliphatic protons can be distinguished well from the resulting benzhydryl-proton signals and identified by a before/after comparison. The .sup.1H-NMR spectrum shows a singlet at δ=8.56 ppm, which is typical of a carbocationic species. The existence of this species is hardly surprising due to the use of a very strong acid as a solvent, which might have dehydrated the PEEK-OH. The carbocation is well resonance-stabilized due to its positioning between two aromatic systems, and can be measured this way. Furthermore, a further new signal can be taken from the spectrum at 3.41 ppm, which might correspond to the benzhydryl proton. The fine splitting of the signal is a doublet with a coupling constant of 3.1 Hz. This might result from the .sup.4J-coupling of the benzhydryl proton to the aromatic protons. An HSQC-NMR experiment showed a coupling of the carbocationic proton signal to a carbon signal, which appears at a shift of 113.8 ppm. The signal identified as benzhydryl couples to a carbon signal at a shift of 34.5 ppm, which would correspond to a success of the reaction.
[0110] Further, the surface was analyzed by ATR-IR spectroscopy. The spectrum is shown in
[0111] The surface of the material was further analyzed with XPS and compared to the unmodified material. The overview spectrum and the corresponding fine spectra are shown in
TABLE-US-00002 TABLE 2 Summary of the XPS analysis of PEEK-OH. Component Element Element/ BE Composition Concentration Assignment Transition [eV] [at. %] [at. %] Carbon C 1s 284.7 63.09 68.4 C 1s 286.3 32.25 C 1s 286.5 2.34 C 1s 291.5 2.32 Oxygen O 1s 531.1 11.1 31.6 O 1s 532.2 32.2 O 1s 533.3 51.4 O 1s 539.8 5.3
[0112] The surface of the PEEK-OH material was further examined with atomic force microscopy. Before the reaction, the maximum height difference was 17 to 33 nm in a 16 μm.sup.2 analysis area. After the reaction, the maximum height difference was 208 nm (
[0113] Measurements of water contact angle showed a decrease of the contact angle from previously 89° of the unmodified material to 77° of the modified material, which means an increase in the hydrophilicity of the surface.
[0114] Due to the strong autofluorescence of the PEEK material, no fluorescent dyes were used as indirect evidence and for a possible quantification.
Example 3
Coupling of Linker Molecules—PEEK-COOH
[0115] In order to ensure covalent binding of the gelatin molecules to the PEEK-OH surface, it has to be modified chemically with appropriate linker molecules. The reactions specified below are possible here. In the case of metal oxide surfaces, silanes would be used as linker molecules.
[0116] In order to create a surface with acid groups, a linker molecule was bound to the surface via an ester bond. This should be a dicarboxylic acid, which is interconnected by methylene groups of a variable number. Exemplarily, the reaction was carried out on a succinic acid linker.
[0117] This was realized with the help of N,N′-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP). Typically, during the reaction procedure, two equivalents of succinic acid were initially dissolved in tetrahydrofuran (THF) and cooled with an ice bath. Then one equivalent of DCC and 0.1 equivalent of DMAP were added to the cooled solution. After four hours, the PEEK-OH sheets were added into this solution and stirred for a further four days at room temperature. Thereafter, the sheets were washed three times with THF and three times with acetone. Drying was finally carried out in a vacuum oven at 40° C. and 50 mbar. The reaction scheme of the coupling of the succinic acid linker is shown in
[0118] The sheets were examined with ATR-IR spectroscopy (
[0119] Furthermore, NMR spectroscopy was used to verify the success of the reaction (
[0120] Moreover, contact angle measurements were carried out on this product as well. They showed a further decrease of the water contact angle of previously 77° of the precursor to 70° of the PEEK-COOH. This result indicates a further increase in hydrophilicity.
Example 4
Coupling of Linker Molecules—PEEK-Maleimide
[0121] Coupling reagents, which can form bonds with thiol groups, such as maleimide linkers, are widespread among protein and other bioconjugation techniques. In proteins, thiol groups are often involved in disulfide bonds, crosslinking via such groups changing the protein structure only insignificantly. Thiol groups also occur in most proteins, but they are not as numerous as primary amines and make the coupling reaction much more selective. Another advantage of a thioether bond is its irreversibility. The Mitsunobu reaction is often used for bonding such molecules. The reaction scheme of the coupling of the maleimide to PEEK-OH is shown in
[0122] For this purpose, the PEEK-OH sheet was immersed in a solution of triphenylphosphine, diethyl azodicarboxylate, and maleimide in THF and stirred for 24 hours at room temperature. Thereafter, the sheet was washed with a solution of ether/hexane (1:1) four times and subsequently dried in a vacuum oven for at least three hours at 60° C. and 50 mbar. The product PEEK-maleimide will be mentioned hereinafter.
[0123] Subsequently, the PEEK-maleimide sheet was examined with ATR-IR spectroscopy. In the spectrum (
[0124] An analysis with energy-dispersive X-ray spectroscopy (EDX) shows the presence of nitrogen on the surface. Under almost neutral reactions conditions (pH 6.5 to 7.5), preferably stable thioether bonds form. Under more alkaline reaction conditions (pH>8.5), preferably primary amines bind, wherein at the same time the hydrolysis rate of the maleimide group to an unreactive maleamic acid increases.
Example 5
Coupling of Linker Molecules—PEEK NCO
[0125] In a parallel approach, a homobifunctional hexamethylene diisocyanate (HMDI linker) was used. It can form stable isourea bonds with amines, among others. Such isocyanate linkers are also capable of coupling molecules including a hydroxyl group, such as polysaccharides, in a carbamate/urethane bond. For the modification of PEEK, the PEEK-OH sheet was immersed in a solution of hexamethylene diisocyanate and catalytic amounts of 1,4-diazabicyclo[2.2.2]octane (DABCO) in toluene and stirred for three days at room temperature. The reaction was carried out in a protective atmosphere under dry reaction conditions. After the reaction time, the sheet was washed twice with toluene and with acetone and finally dried in a vacuum oven for at least three hours at 30° C. and 50 mbar. The resulting product PEEK-NCO will be mentioned hereinafter. The reaction scheme of the coupling of hexamethylene diisocyanate to PEEK-OH is shown in
[0126] After the reaction, the PEEK-NCO sheets were examined with ATR-IR spectroscopy. The spectrum (
[0127] The surfaces of the material were further examined with XPS and compared to the unmodified material. The reference material used here was silicon. The overview spectrum is shown in
[0128] The oxygen content was 35.6% with an O.sub.1S component at 532.0 eV. By fitting the fine spectrum, oxygen was identified in three different chemical environments. A signal at 531.1 eV, which was assigned to the C═O component, a signal at 532.6 eV, which was assigned to the O—H component, and a signal at 533.3 eV, which was assigned to the O—C component. These signals have a relative intensity of 22.6%, 9.9%, and 57.5%. In this evaluation, however, it has to be taken into account that the HMDI linker can undergo many side reactions, which with this type of evaluation can have negative effects. For example, HMDI linkers among each other can form a dimer or multimer on the surface thus forming an allophanate group. As only the top few nanometers are analyzed through XPS, it is difficult to estimate the exact component concentration after such polymerization of the linkers.
TABLE-US-00003 TABLE 3 Summary of XPS measurement of PEEK-NCO. Component Element Element/ BE composition concentration Assignment Transition [eV] [at. %] [at. %] Carbon C 1s 284.7 39.1 54.92 C 1s 285.2 53.2 C 1s 287.0 1.35 C 1s 289.3 2.85 C 1s 285.5 2.4 C 1s 286.5 1.06 Oxygen O 1s 531.1 22.6 35.6 O 1s 532.6 19.9 O 1s 533.3 57.5 Nitrogen N 1s 399.9 30 9.2 N 1s 399.0 70 Silicon Si 2s 149 0.28
[0129] Due to lack of hydrolysis resistance of the HMDI linkers to water, a contact angle measurement was dispensed with.
[0130] Scanning electron microscopy shows a relatively smooth, homogeneous surface. An analysis with EDX confirmed the presence of nitrogen on the surface. The nitrogen concentration was 7.67% here.
Example 6
Coupling of Biomolecules—Coupling Via EDC
[0131] To test the reaction process and for the optimization of reaction conditions, the gelatin was selected as to be biomolecule to be coupled in view of the higher costs of collagen, as gelatin is mainly denatured collagen.
[0132] Coupling of the gelatin was carried out with the aid of 1-ethyl-3-(3-dimethylamino-propyl)carbodiimide hydrochloride (EDC). This is a widely used and commercially available coupling reagent, which is frequently used for the chemical coupling of proteins and peptides, proteins and oligonucleotides or biomolecule and particle surfaces. Together with N-hydroxysuccinimide (NHS), a reaction of carboxylates and amines thus forming an amide bond is promoted in particular. EDC coupling reactions are usually carried out under acidic reaction conditions (pH 4.5 to 5.5). The reaction scheme of the coupling of gelatin to PEEK-COOH is shown in
[0133] In order to prevent easy coupling of the gelatin molecules among each other, first the surface of PEEK-COOH was activated with the EDC/NHS solution, and the films were finally transferred from this solution into a gelatin solution and stirred for a further four hours. Subsequently, the sheet was washed at least three times with 40° C.-warm water to wash off adsorbed gelatin. Finally, the sheet was washed with ethanol and dried, which at the same time precipitates the remaining gelatin molecules on the surface. The resulting sheet will be referred to as PEEK gelatin hereinafter.
[0134] The PEEK gelatin sheets were finally examined with ATR-IR spectroscopy. Here, however, no significant differences in the spectrum compared to the precursor were detected. This is probably due to the overlap of the very strong characteristic bands for the PEEK material and the comparatively weaker bands of amide bands, which would also have to appear in the same wave number range
[0135] To verify the success of the reaction of the reaction nonetheless, further analysis methods were used. The surface was further examined with scanning electron microscopy. The image (
[0136] To get an impression of the thickness of the gelatin layer, the gelatin PEEK sheet was cut and the edge face was examined by means of scanning electron microscopy (
[0137] A thermogravimetric examination revealed a mass fraction of 25 percent by weight of gelatin in the analysis substance.
Example 7
Coupling of the Biomolecules—Coupling Via Isocyanate Linker
[0138] Coupling of the gelatin to the surface of the PEEK-NCO took place from a solution of gelatin in DMSO. The reaction scheme of the coupling of gelatin via an isocyanate linker is shown in
[0139] ATR-IR spectroscopic examinations showed a disappearance of the characteristic isocyanate signal at 2267 cm′ in a before/after comparison, which is indicative of a gelatin coupling having taken place.
Example 8
Coupling of Biomolecules—Coupling Via Maleimide Linker
[0140] Coupling of the gelatin to the surface of the PEEK maleimide took place from a solution of gelatin in water. For this purpose, the PEEK maleimide sheet was stirred in a 3% solution of gelatin in water for 3 hours at room temperature. Subsequently, the sheet was washed three times with warm water, and finally was washed once with acetone. Drying of the sheet was carried out in a vacuum oven for at least three hours at 40° C. and 50 mbar. Also in this case was the surface examined with scanning electron microscopy. The image (
[0141] ATR-IR spectroscopic examinations showed a disappearance of the characteristic isocyanate signal at 2870 cm.sup.1 in a before/after comparison, which is indicative of a gelatin coupling having taken place.
Example 9
Biomineralisation
[0142] To finally mineralize the covalently coupled gelatin layer, the PEEK gelatin sheet was immersed in a 2-(4-(2-hydroxyethyl)-1-piperazinyl)ethanesulfonic acid (HEPES) buffer solution containing calcium chloride, dipotassium hydrogen phosphate, and poly-aspartic acid for four days at 37° C.
[0143] Finally, the sheets were washed with water at least three times and with ethanol three times. Drying of the material was carried out in a vacuum oven (40° C. at 50 mbar). The resulting material will be referred to as PEEK-HAp hereinafter.
[0144] The surface was examined using scanning electron microscopy (
TABLE-US-00004 TABLE 4 Summary of the EDX results of the mineralized PEEK sheet Mass percent Atomic (norm) percent Element AN Seriess [wt %] [at. %] Carbon 6 K-Series 77.48 82.45 Oxygen 8 K-Series 21.52 17.19 Calcium 20 K-Series 0.64 0.2 Phosphorus 15 K-Series 0.23 0.1 Sulfur 16 K-Series 0.14 0.05
[0145] To identify this calcium phosphate layer, a thin cut through the material was prepared by means of an FIB cut (
Example 10
In Vitro Evaluation of the Materials
[0146] In order to examine the biocompatibility, the PEEK-HAp sheets were finally subjected to various in vitro tests. These tests were conducted according to the EN ISO 10993-5:2009 directive on the biological evaluation of medical devices, in particular part 5 for assessing the in vitro cytotoxicity of biomaterials. All tests were carried out in appropriate statistical replicas.
[0147] First, by means of an indirect toxicological study, it was intended to find out of whether toxic substances can be detached from or dissolved out of the material. For testing the extracts, the material 24 was swirled in cell culture medium at 37° C. for 24 hours. Finally, the cell culture medium was incubated in cell culture medium with L-929 fibroblasts (P14) for two days in undiluted form and at dilutions of 1:2, 1:4, and 1:10. Subsequently, the degree of cell destruction was analyzed by means of light microscopy, and cell viability was analyzed by means of an MTT assay. The applicability of this test was confirmed by means of a positive and negative control. Light microscopy showed that no more than 10% of the cells on PEEK-gelatin films and PEEK-HAp films have a round shape and that no discrete intracellular granules were in the cells, which corresponds to non-reactivity overall. Also, no cell lysis or blank areas were found. The MTT test showed a cell viability of over 90%. Thus, the materials can be considered to be non-toxic.
[0148] Complementarily, a direct toxicological examination was performed on PEEK and PEEK-HAp material. To this end, NIH 3T3 fibroblasts were incubated directly on the material for 24 hours and, thereafter, the relative cell viability using an MTT assay was determined. A light-microscopic evaluation was carried out only partly due to the opacity of the material. The applicability of this test was also confirmed by application of a positive control. With the light-microscopic examination, no cell lysis or blank areas were found. The MTT test showed a cell viability of the cells of over 95%±0.2.9. The material can thus be regarded as non-toxic.
[0149] After the toxicological studies, the relative proliferation, viability, and adhesion behavior of human fibroblasts (NHDF—“normal human dermal fibroblast”) of a low passage number on the modified material as compared to the unmodified material was examined.
[0150] For proliferation, a certain number of cells was incubated on the surface of the materials for 24 hours. Thereafter, the cells were released from the material and their number was determined using a CASY counting device. This examination showed that the cells proliferate better on the PEEK-HAp material by a factor of 4.4 than on the unmodified PEEK. At the same time, the proliferation was examined at the intermediate stage of the PEEK-gelatin material. It was found that the fibroblasts proliferate better by a factor of 2.5 than on the unmodified material. Thus, it follows that the fibroblasts proliferate better on the PEEK-gelatin material and even better on the PEEK-HAp material. The results are shown in
[0151] Complementarily, the cell viability was examined using an MTT assay. This examination showed that the cell viability on the PEEK-gelatin material is higher by a factor of 1.8, based on the unmodified PEEK material, and on the PEEK-HAp material higher by a factor of 3.9. Since the cell viability is directly correlated with the cells number, this test is also a control for the proliferation test. This test also shows that the fibroblasts proliferate better on the PEEK-gelatin material and even better on the PEEK HAp material than on the unmodified PEEK. The results are shown in
[0152] The cell adhesion of the fibroblasts on the materials was also examined. For this, a certain number of cells was seeded on the materials and incubated on the material for an adhesion time typical of fibroblasts. After this time, all non-adherent cells were washed off. In this step, a reproducible wash rate is particularly important. After this washing step, the adherent cells were detached from material and their number was determined by means of a Neubauer counting chamber. This examination showed that the fibroblasts, in the absence of cell culture serum, adhere better on the PEEK-gelatin material by a factor of 1.5 and on the PEEK-HAp material by a factor of 2.3 than on the unmodified PEEK. This assay was performed both in the presence and in the absence of serum in cell culture medium. This is based on the basis that it has to be examined whether the altered adhesion of the cells is due to the proteins in the cell culture medium, which adsorb on the material surface, or due to the surface modification made. The presence of cell culture serum increases the adhesion of fibroblasts by 28% on average. The results are shown in
[0153] Other features which are considered as characteristic for the invention are set forth in the appended claims.
[0154] Although the invention is illustrated and described herein as embodied in material for bone implants and method of producing same, it is nevertheless not intended to be limited to the details shown, since various modifications and structural changes may be made therein without departing from the spirit of the invention and within the scope and range of equivalents of the claims.